LIRUSSI, FLAVIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.395
AS - Asia 1.072
EU - Europa 677
SA - Sud America 217
AF - Africa 188
OC - Oceania 31
Continente sconosciuto - Info sul continente non disponibili 13
Totale 4.593
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.277
SG - Singapore 432
CN - Cina 211
HK - Hong Kong 138
BR - Brasile 137
FI - Finlandia 80
VN - Vietnam 74
DE - Germania 68
NL - Olanda 62
IT - Italia 61
PL - Polonia 47
SE - Svezia 42
FR - Francia 40
UA - Ucraina 29
RU - Federazione Russa 26
GB - Regno Unito 21
AR - Argentina 15
BY - Bielorussia 14
IQ - Iraq 14
RS - Serbia 12
AU - Australia 11
CA - Canada 11
CY - Cipro 11
EC - Ecuador 11
IN - India 11
MG - Madagascar 11
NP - Nepal 11
PY - Paraguay 11
BS - Bahamas 10
CO - Colombia 10
ID - Indonesia 10
JO - Giordania 10
MU - Mauritius 10
RO - Romania 10
UG - Uganda 10
AO - Angola 9
BD - Bangladesh 9
BE - Belgio 9
GR - Grecia 9
HU - Ungheria 9
IE - Irlanda 9
MD - Moldavia 9
AT - Austria 8
CH - Svizzera 8
ET - Etiopia 8
KZ - Kazakistan 8
LU - Lussemburgo 8
MX - Messico 8
NO - Norvegia 8
PA - Panama 8
PT - Portogallo 8
SK - Slovacchia (Repubblica Slovacca) 8
TR - Turchia 8
AE - Emirati Arabi Uniti 7
AZ - Azerbaigian 7
CZ - Repubblica Ceca 7
ES - Italia 7
GF - Guiana Francese 7
IS - Islanda 7
LC - Santa Lucia 7
NI - Nicaragua 7
NZ - Nuova Zelanda 7
SO - Somalia 7
TL - Timor Orientale 7
TT - Trinidad e Tobago 7
VE - Venezuela 7
ZA - Sudafrica 7
AF - Afghanistan, Repubblica islamica di 6
BB - Barbados 6
BJ - Benin 6
CW - ???statistics.table.value.countryCode.CW??? 6
EE - Estonia 6
GM - Gambi 6
GN - Guinea 6
HN - Honduras 6
KE - Kenya 6
KG - Kirghizistan 6
KH - Cambogia 6
KR - Corea 6
LA - Repubblica Popolare Democratica del Laos 6
LB - Libano 6
MA - Marocco 6
MY - Malesia 6
SN - Senegal 6
TW - Taiwan 6
UY - Uruguay 6
UZ - Uzbekistan 6
ZM - Zambia 6
AL - Albania 5
BG - Bulgaria 5
CG - Congo 5
CL - Cile 5
CR - Costa Rica 5
CU - Cuba 5
DK - Danimarca 5
GA - Gabon 5
HR - Croazia 5
HT - Haiti 5
LV - Lettonia 5
ME - Montenegro 5
Totale 4.393
Salva come PNG Salva come JPEG
Città #
Singapore 242
Fairfield 225
Woodbridge 219
Santa Clara 212
Ann Arbor 205
Ashburn 177
Jacksonville 147
Chandler 142
Hong Kong 133
Houston 109
Wilmington 106
Princeton 71
Beijing 68
Cambridge 66
Boardman 65
Seattle 58
Roxbury 46
Bytom 34
Medford 31
Nanjing 30
Helsinki 24
Dong Ket 23
San Diego 23
Ho Chi Minh City 16
Hanoi 14
New York 14
Munich 13
São Paulo 13
Nanchang 12
Des Moines 11
Amman 10
Antananarivo 10
Kampala 10
Nassau 10
Shenyang 10
Changsha 9
Jiaxing 9
Luanda 9
Norwalk 9
Tianjin 9
Los Angeles 8
Panama City 8
Washington 8
Castries 7
Chicago 7
Dublin 7
Milan 7
Minsk 7
Vienna 7
Addis Ababa 6
Bishkek 6
Bridgetown 6
Cotonou 6
Dakar 6
Dili 6
Guangzhou 6
Guayaquil 6
Hefei 6
London 6
Lusaka 6
Managua 6
Nicosia 6
Rome 6
Warsaw 6
Athens 5
Baghdad 5
Baku 5
Belgrade 5
Boydton 5
Brooklyn 5
Budapest 5
Cayenne 5
Conakry 5
Hargeisa 5
Khartoum 5
Libreville 5
Luxembourg 5
Montevideo 5
Nairobi 5
Niamey 5
Phnom Penh 5
Port Louis 5
Port Moresby 5
Redwood City 5
Reykjavik 5
Riga 5
Tashkent 5
Ulan Bator 5
Vientiane 5
Willemstad 5
Accra 4
Bamako 4
Bogotá 4
Brasília 4
Bălţi 4
Dhaka 4
Erbil 4
Havana 4
Johannesburg 4
Kathmandu 4
Totale 2.970
Salva come PNG Salva come JPEG
Nome #
The monoethylglycinexylidide test for grading of liver cirrhosis 179
Epidemiology of unconjugated hyperbilirubinemia revisited 164
Antioxidant supplements for non-alcoholic fatty liver disease and/or steatohepatitis 152
Macro-aspartate aminotransferase ("Macro-AST"). A 12-year follow-up study in a young female 146
Hepatitis C virus infection in a resident elderly population: A 10-year follow-up study 145
Probiotics for non-alcoholic fatty liver disease and/or steatohepatitis 134
Clinical significance of serum bilirubins:recent advances. 134
Congenital anomalies of the liver: laparoscopic observations 133
Effetto del glucosio e dell'uridin-difosfoglucosio (UDPG) sulla iperbilirubinemia da dogiuno nella sindrome di Gilbert. 127
Antipyrine clearance: evaluation of simplified methods in chronic liver diseases. 122
Smooth liver surface may conceal cirrhosis. Evidence for the late development of nodular surface of the cirrhotic liver. 119
Bile acids for non-alcoholic fatty liver disease and/or steatohepatitis. (Protocol) 115
Paravaterian diverticula presenting as acute cholangitis in two very elderly patients. 110
Antioxidant supplements for non-alcoholic fatty liver disease and/or steatohepatitis. (Protocol) 109
Validity of laparoscopy after abdominal surgery. 108
Laparoscopy and guided liver biopsy in the diagnosis of cirrhosis: conventional technique vs minilaparoscopy 106
Adrenocortical carcinoma: a 15-year survival after complete resection and repeated resection. A retrospective study in a patient with an expected poor prognosis 102
Needle and trocar injuries in diagnostic laparoscopy under local anesthesia: what is the true incidence of these complications? 95
DELAYED RECOGNITION OF INADVERTENT GUT INJURY DURING LAPAROSCOPY. 90
Retained cholesterol intrahepatic bile duct stones: efficacy of high-dose short-term ursodeoxycholic acid administration. 90
AGENESIS OF THE GALLBLADDER ASSOCIATED WITH GILBERT'S SYNDROME. A THIRTY-YEAR FOLLOW-UP STUDY. 89
Biliary excretion of simultaneously administered bilirubin and chenodeoxycholic acid in rats. 89
La sindrome dell'intestino corto: fisiopatologia, clinica ed orientamenti terapeutici 89
Biliary lipid composition after endoscopic sphincterotomy in postcolecystectomy patients: effect of short term ursodeoxycholic acid administration. 89
The pharmacokinetics of H2 receptor blocking agents in compensated liver cirrhosis. 83
Metabolismo dei farmaci in corso di cirrosi epatica 83
Treatment of active cirrhosis with ursodeoxycholic acid and a free radical scavenger. A two-year prospective study. 82
Prevalence of cholelithiasis in a elderly resident population 81
Ciclosporina ed epatotossicità:revisione della letteratura. 79
Interferences between the metabolism of bile salts and Rifamycin SV in rats. 79
Monoethylglycinexylidide kinetics and galactose elimination capacity during treatment with interferon-alfa for hepatitis C virus infection:Possible predictors of response? 78
Silent stones: how many patients are suitable for bile acid therapy? 77
Influence of age and sex on the distribution of serum bilirubin in a healthy population. 76
Biliary excretion of simulateously administered bilirubin and chenodeoxycholic acid in rats with porta-caval shunt. 75
Nuove acquisizioni sulla patogenesi e terapia dell'encefalopatia porto-sistemica. 74
BLADDER INJURY DURING DIAGNOSTIC LAPAROSCOPY. A CASE REPORT. 73
Complicanze laparoscopiche in età geriatrica: osservazioni su 345 casi consecutivi 72
Colite pseudomembranosa: malattia batterica da inappropriato uso degli antibiotici. 70
Secrezione lipidica biliare e farmaci ipolipemizzanti 70
Le colemie familiari 67
Oral and intravenous pharmacokinetics of cimetidine in liver cirrhosis. 66
Litiasi biliare colesterolica. recenti acquisizioni e prospettive di terapia medica. 66
Probiotics for non-alcoholic fatty liver disease and/or steatohepatitis.(Protocol) 66
Litiasi biliare colesterolica: terapia medica o chirurgica? 64
Is laparoscopy still useful in the follow-up of chronic active hepatitis? 64
Effect of phalloidin on hepatic transport of bilirubin in rats. 61
Il megacolon toosico 56
Laparoscopic hazards in liver patients. Need to review the current classification of the complications in diagnostic laparoscopy. 54
Laparoscopy in the elderly: is it hazardous? 49
Totale 4.601
Salva come PNG Salva come JPEG
Categoria #
all - tutte 13.801
article - articoli 11.160
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.641
Totale 27.602
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021189 0 0 0 0 11 26 2 30 38 20 25 37
2021/2022413 1 77 28 41 17 5 7 42 12 2 32 149
2022/2023339 83 26 3 29 58 52 2 21 38 3 17 7
2023/2024214 7 21 26 13 26 58 11 2 2 1 26 21
2024/20251.033 2 60 48 41 278 20 35 40 70 36 161 242
2025/20261.255 96 303 364 383 109 0 0 0 0 0 0 0
Totale 4.601